NASDAQ:AIPT - Precision Therapeutics Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$0.75 0.00 (0.00 %)
(As of 12/14/2018 04:00 PM ET)
Previous Close$0.75
Today's Range$0.7021 - $0.7780
52-Week Range$0.65 - $1.58
Volume15,992 shs
Average Volume32,987 shs
Market Capitalization$9.74 million
P/E RatioN/A
Dividend YieldN/A
Beta1.19
Precision Therapeutics Inc. provides various healthcare products and services primarily in the United States. The company manufactures environmentally conscious systems for the collection and disposal of infectious fluids that result from surgical procedures and post-operative care. It offers the STREAMWAY Fluid Waste Management system that suctions surgical waste fluid from the patient using standard surgical tubing; and disposables. The company also provides contract research organization (CRO) that offers personalized medicine solutions for pharmaceutical, diagnostic, and biotech industries. Its CRO services enhance the effectiveness of cancer therapy using the power of artificial intelligence applied to diseases databases. The company markets and sells its STREAMWAY Fluid Waste Management system and procedure disposables to medical facilities through various direct sales force and independent distributors. The company was formerly known as Skyline Medical Inc. and changed its name to Precision Therapeutics Inc. in February 2018. Precision Therapeutics Inc. was founded in 2002 and is based in Eagan, Minnesota.

Receive AIPT News and Ratings via Email

Sign-up to receive the latest news and ratings for AIPT and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange NASDAQ
Industry Surgical appliances & supplies
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:AIPT
Previous Symbol
CUSIPN/A
Phone651-389-4800

Debt

Debt-to-Equity RatioN/A
Current Ratio1.30
Quick Ratio1.19

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual Sales$650,000.00
Price / Sales14.99
Cash FlowN/A
Price / Cash FlowN/A
Book Value$0.24 per share
Price / Book3.13

Profitability

EPS (Most Recent Fiscal Year)N/A
Net Income$-7,740,000.00
Net Margins-719.83%
Return on Equity-266.54%
Return on Assets-199.98%

Miscellaneous

Employees17
Outstanding Shares12,990,000
Market Cap$9.74 million
OptionableNot Optionable

Precision Therapeutics (NASDAQ:AIPT) Frequently Asked Questions

What is Precision Therapeutics' stock symbol?

Precision Therapeutics trades on the NASDAQ under the ticker symbol "AIPT."

How were Precision Therapeutics' earnings last quarter?

Precision Therapeutics Inc (NASDAQ:AIPT) released its quarterly earnings results on Wednesday, November, 14th. The medical instruments supplier reported ($0.19) EPS for the quarter. The medical instruments supplier had revenue of $0.33 million for the quarter. Precision Therapeutics had a negative return on equity of 266.54% and a negative net margin of 719.83%. View Precision Therapeutics' Earnings History.

When is Precision Therapeutics' next earnings date?

Precision Therapeutics is scheduled to release their next quarterly earnings announcement on Monday, April 1st 2019. View Earnings Estimates for Precision Therapeutics.

Has Precision Therapeutics been receiving favorable news coverage?

News headlines about AIPT stock have been trending somewhat positive this week, according to InfoTrie Sentiment Analysis. The research firm identifies positive and negative news coverage by monitoring more than six thousand blog and news sources in real time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Precision Therapeutics earned a media sentiment score of 1.2 on InfoTrie's scale. They also gave press coverage about the medical instruments supplier a news buzz of 6.0 out of 10, indicating that recent news coverage is somewhat likely to have an impact on the stock's share price in the near future.

Who are some of Precision Therapeutics' key competitors?

Who are Precision Therapeutics' key executives?

Precision Therapeutics' management team includes the folowing people:
  • Dr. Carl I. Schwartz, CEO & Director (Age 77)
  • Mr. Robert L. Myers, CFO & Sec. (Age 63)
  • Mr. David Orrin Johnson, Sr. VP of Operations - Skyline Medical Bus. Unit (Age 65)
  • Mr. Kevin Hungerford, VP of Sales & Marketing
  • Mr. David Dauwalter, Director of Product Management

How do I buy shares of Precision Therapeutics?

Shares of AIPT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Precision Therapeutics' stock price today?

One share of AIPT stock can currently be purchased for approximately $0.75.

How big of a company is Precision Therapeutics?

Precision Therapeutics has a market capitalization of $9.74 million and generates $650,000.00 in revenue each year. Precision Therapeutics employs 17 workers across the globe.

What is Precision Therapeutics' official website?

The official website for Precision Therapeutics is http://www.skylinemedical.com.

How can I contact Precision Therapeutics?

Precision Therapeutics' mailing address is 2915 COMMERS DRIVE SUITE 900, EAGAN MN, 55121. The medical instruments supplier can be reached via phone at 651-389-4800 or via email at [email protected]


MarketBeat Community Rating for Precision Therapeutics (NASDAQ AIPT)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  80 (Vote Outperform)
Underperform Votes:  82 (Vote Underperform)
Total Votes:  162
MarketBeat's community ratings are surveys of what our community members think about Precision Therapeutics and other stocks. Vote "Outperform" if you believe AIPT will outperform the S&P 500 over the long term. Vote "Underperform" if you believe AIPT will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 12/15/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel